NEC: Harnessing Artificial Intelligence-Powered Drug Development to Provide Tailored Medicines
Summary by Nature
4 Articles
4 Articles
All
Left
Center
2
Right
NEC: harnessing artificial intelligence-powered drug development to provide tailored medicines
Individualized cancer therapies represent the next step for cancer immunotherapy. NEC Corporation has developed cutting-edge artificial intelligence to predict patient-specific neoantigens to turn this promise into reality and extend the approach to infectious diseases.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage